Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-06-20

FDA Approved: JUNIOR STRENGTH ADVIL — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approves a supplemental application for JUNIOR STRENGTH ADVIL (ibuprofen) from Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JUNIOR STRENGTH ADVIL (IBUPROFEN)

Snippet

SUPPL AP for JUNIOR STRENGTH ADVIL (IBUPROFEN)